|
Evaxion A/S
(NASDAQ: EVAX)
|
9:00 PM UTC, 12/12/25 | |||
|---|---|---|---|---|
| Last: $6.21 | Change: -0.24 | %Change: -3.72% | Volume: 70,895 | |
11:08 AM EST, 02/26/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.80% to 1,430.76 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and brewing company Anheuser-Busch InBev (BUD), which climbed 11.3% and 8.9% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company Cellectis (CLLS), which increased 3.7% and 3.6% respectively.
The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and semiconductor company Sequans Communications (SQNS), which fell 0.7% and 0.5% respectively. They were followed by telecommunications company Nokia (NOK) and internet advertising firm Criteo (CRTO), which were off 0.5% and 0.1% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Biodexa Pharmaceuticals (BDRX), which rose 4.8% and 4.4% respectively. They were followed by financial services company Lloyds Banking Group (LYG) and medical device maker Smith & Nephew (SNN), which were up 4.1% and 3.2% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm (TCBP) and Adaptimmune Therapeutics (ADAP), which lost 7.8% and 2.6% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and software company Endava (DAVA), which were down 0.8% and 0.6% respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.